Sofinnova Investments, Inc. Regenxbio Inc. Transaction History

Sofinnova Investments, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$22.29 - $35.04 $12.5 Million - $19.7 Million	-562,665 Reduced 72.45%	213,959 $5.66 Million
Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $3.15 Million - $5.7 Million	162,539 Added 26.47%	776,624 $19.2 Million
Q1 2022 May 16, 2022	SELL	$24.62 - $34.31 $9.7 Million - $13.5 Million	-393,996 Reduced 39.08%	614,085 $20.4 Million
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $26.6 Million - $35.5 Million	880,488 Added 690.08%	1,008,081 $33 Million
Q3 2021 Nov 15, 2021	SELL	$29.09 - $45.68 $8.73 Million - $13.7 Million	-300,147 Reduced 70.17%	127,593 $5.35 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $2.14 Million - $2.67 Million	66,005 Added 18.25%	427,740 $16.6 Million
Q1 2021 May 14, 2021	BUY	$33.61 - $49.95 $3.05 Million - $4.53 Million	90,621 Added 33.43%	361,735 $12.3 Million
Q4 2020 Feb 16, 2021	BUY	$26.52 - $49.35 $5.61 Million - $10.4 Million	211,607 Added 355.6%	271,114 $12.3 Million
Q3 2020 Nov 13, 2020	BUY	$27.01 - $40.26 $1.61 Million - $2.4 Million	59,507 New	59,507 $1.64 Million

193

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $339M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.